$GTCH Using a secured portal, fabless IC design firms will

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
178
$GTCH Using a secured portal, fabless IC design firms will be able to license and use GBT’s IC analysis programs per demand. This system will potentially offer an affordable solution for small and medium integrated design companies that cannot afford mass licensing model costs. Typically, these types of software are licensed based on the number of users, and in case of large corporations via a site license model. This method may not be affordable to many small and medium size IC design firms. Establishing a per-demand, per-user license leasing feature may open new business opportunities for many IC design houses around the world.

GBT, upon completion of the portal, plans to offer a wide variety of IC analysis and verification programs within the fields of Design Rule Check, Reliability, Electrical Connectivity, and DFM (Design for Manufacturing). Once developed, the secured web portal will offer the option of analysis run on the customer’s machines or on GBT’s secured servers with the goal of correcting and/or improving the microchip’s characteristics and confirming the desired outcome. Corporations will be able to license GBT’s software tools per session and usage period; for example, per week, month or more. The licensing cost will be calculated according to usage time, number of users and the leased software tools. In the past decade the IC’s industry has experienced high demand for computer-aided-design (CAD), also called EDA (Electronic Design Automation), software tools as these become key aspects in transforming product’s definition and concepts into production-ready integrated circuits. GBT intends to make its technology available for all IC design firms sizes enabling them to achieve their goals and introduce their projects to market in an affordable manner.

“Large microchip design companies typically pay millions of dollars annually to license a complete set of EDA tools that are necessary to design IC projects; particularly, in advanced nanometer nodes. But not every design firm can afford this cost. For example, startups or medium size corporations are struggling paying high licensing cost of EDA tools to ensure well designed projects. Using a per-demand, per user licensing model, we plan to offer our IC analysis technology in much more affordable prices. As large corporations will be able to license our technology according to their capabilities, smaller and medium firms will also benefit from advanced IC analytics tools in an affordable cost. We plan to offer this type of licensing through a secured web portal that will provide time/user based, per-demand leasing option. Design firms will have the option to run GBT’s software on their own servers or to upload their design to be processed on our secured computing environment. We will offer our Design Rule, Reliability, Connectivity and DFM analysis tools. We plan to incorporate advanced data security technology to protect design firm’s IP and analysis results. We firmly believe that such a system may create a whole world of business opportunities, offering significant productivity enhancement technology, enabling a major project’s design time reduction, with higher quality, and much faster timelines to market” stated Danny Rittman, the Company’s CTO.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 87

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 68

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 43

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 730

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 323

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 226

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 73

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 490

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 228

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
aria-label="Continue reading: JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer"> Continue Reading